Evidence map›Paper›PMID 30881062›Full record

ArticleInfection and drug resistance2019

High rates of CTX-M group-1 extended-spectrum β-lactamases producing

Ghazanfar Abbas, Iahtasham Khan, Mashkoor Mohsin, Sajjad-Ur-Rahman, Tayyaba Younas, Shahzad Ali

Abstract read
In one paragraph

Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Antimicrobial resistantOne health (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antimicrobial Resistance inMicroorganisms · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Antibiotic-ResistantMicroorganisms · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ghazanfar AbbasInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan, mashkoormohsin@uaf.edu.pk.
Iahtasham KhanSection of Epidemiology and Public Health, Department of Clinical Sciences, University of Veterinary and Animal Sciences, Jhang, Pakistan.
Mashkoor MohsinInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan, mashkoormohsin@uaf.edu.pk.
Sajjad-Ur-RahmanInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan, mashkoormohsin@uaf.edu.pk.
Tayyaba YounasInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan, mashkoormohsin@uaf.edu.pk.
Shahzad AliDepartment of Wildlife and Ecology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePet animals have been considered a potential carrier of clinically important multi-drug-resistant

methodsA total of 105 fecal samples were collected from dogs, cats, their owners, and veterinary professionals from veterinary clinics. Isolates of ESBL-producing

resultsOf the 105 fecal samples screened, 73 (69.5%) were found to contain ESBL-producing

conclusionOur results provide important baseline information on the potential burden of multidrug-resistant

Indexed as

antimicrobial resistanceESBL-producing E. colimultidrug resistanceone-healthpetszoonosis

Identifiers

PMID30881062
PMCPMC6411320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.